法国和意大利研究人员日前发现与导致结核病的结核分枝杆菌(结核杆菌)毒性有关的蛋白质,并成功培育出其活性减毒突变体,有望在将来研发出比卡介苗更有效的结核病疫苗。 Researchers in France and Italy have recently discovered that proteins associated with the virulence of M. tuberculosis that cause tuberculosis and have succeeded in developing attenuated mutants of their activity are expected to develop tuberculosis vaccines that are more effective than BCG in the future.